Accuracy of a Portable Bladder Scanner to Measure Post-Void Residual Urine Volume in Women with Pelvic Organ Prolapse.

Introduction: Lower urinary tract evaluation in women with pelvic organ prolapse commonly includes measurement of the post-void residual urine volume. Portable bladder scanners may not accurately measure post-void residual urine volume in women with pelvic organ prolapse as the bladder is no longer in its normal anatomical position. In this study we investigated the accuracy of the BladderScan® BVI 9400 to measure post-void residual urine volume in women with prolapse.

The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.

Aims: To investigate the relationship between pontine lesion characteristics on MRI and lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS).

Methods: We performed a prospective cohort study of patients with MS and LUTS who were undergoing brain/spine MRI. Patients were administered the American Urological Association Symptom Score (AUA-SS), Medical, Epidemiologic, and Social Aspects of Aging questionnaire (MESA), and Urogenital Distress Inventory questionnaire (UDI-6), underwent Kurtzke Expanded Disability Status Scale (EDSS) scoring by a neurologist, and had their MRIs reviewed by a neuroradiologist.

The presence of high-grade prostatic intraepithelial neoplasia or atypia on prostate biopsy does not adversely affect prostatectomy outcomes for patients otherwise eligible for active surveillance.

Objective: To investigate if the presence of concomitant high-grade prostatic intraepithelial neoplasia (HGPIN) or atypical small acinar proliferation (ASAP) on biopsy increases the risk of occult adverse pathology in patients otherwise suitable for active surveillance (AS).

Methods: Patients with D'Amico low-risk prostate cancer on ≥ 10-core biopsy who underwent radical prostatectomy at our academic center were evaluated for eligibility for AS by either Epstein criteria or Memorial Sloan Kettering Cancer Center (MSKCC) criteria. Prostatectomy specimens of patients eligible for AS were compared to determine if the presence of clinical HGPIN or ASAP affected the primary outcomes of pathologic upstaging and Gleason score upgrading.